REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Orion Biotechnology Polska Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Orion Biotechnology Polska Sp. z o.o. Profile Updated: October 17, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Orion Biotechnology Polska Sp. z o.o. is a company in Poland, with a head office in Krakow. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was established on November 09, 2015. There are currently 1 (2016) people employed by Orion Biotechnology Polska Sp. z o.o.. Its’ total assets recorded a negative growth of 57.02%.

Headquarters
Ul. Profesora Michala Bobrzynskiego 14
Krakow; Malopolskie; Postal Code: 30-348

Contact Details: Purchase the Orion Biotechnology Polska Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Orion Biotechnology Polska Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Orion Biotechnology Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Orion Biotechnology Polska Sp. z o.o. report to view the information.
Incorporation Date:
November 09, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Orion Biotechnology Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
34.23%▲
Operating profit (EBIT)
69.37%▲
Net Profit (Loss) for the Period
69.37%▲
Total assets
-57.02%▼
Total equity
-2.5%▼
Return on Equity (ROE)
-24.32%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Sartorius Stedim Poland Sp. z o.o.
 
Polpharma Biologics S.A.
Alcid Sp. z o.o.
 
Geneme Laboratories Sp. z o.o.
Genxone S.A.
 
Proper Medical Writing Sp. z o.o.
Biovirtus Research Site Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo